NCT06921226 Exploratory Analysis of Interpersonal and Intrapersonal Psychological Processes Implied in Risk-taking and Suicidal Behaviors, in Adult and Adolescent At-risk
| NCT ID | NCT06921226 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Metropole Savoie |
| Condition | Suicidal Ideas |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,400 participants |
| Start Date | 2025-06-26 |
| Primary Completion | 2027-06-26 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,400 participants in total. It began in 2025-06-26 with a primary completion date of 2027-06-26.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In a recent report, Santé Publique France (2023), reported that 4.2% of 18-85 year-olds had thought about suicide in the last 12 months, and 6.8% had attempted suicide in their lifetime and 0.5% in the last year. Even more recently, the DREES (Direction de la recherche, des études, de l'évaluation et des statistiques auprès des Ministères Sociaux) published a report on May 16, 2024, showing a sharp rise in hospitalization rates for self-inflicted acts among female patients aged between 10 and 24, with a peak around age 15. Two-thirds of these hospitalizations for self-inflicted injuries are related to deliberate drug intoxication. Depression, bipolar disorders and schizophrenia spectrum disorders (among other psychological disorders) are known risk factors for suicide, which is the leading cause of death in this clinical context. In addition to these formalized psychopathological elements, risk behaviors underpinned by psychological processes common to suicide attempts are suspected and need to be studied in depth. Research into psychiatry and the psychopathology of suicide has identified a number of risk and protective factors. These psychological determinants - or processes - act alongside other key factors such as the environment and social ties. Life contexts can have an impact on health, and more specifically on the psychopathology of individuals, through disturbances of a biological, psychological and social nature. It is important to be able to describe what processes are at work and how they explain the development and maintenance of behaviours that put one's life and health at risk. This is part of a preventive approach to mental health. We suggest that the study of psychological processes such as suicidal ruminations, impulsivity and interpersonal needs (e.g. the interpersonal theory of suicide) is necessary to understand their involvement in risk-taking and suicidal behavior. To our knowledge, few studies of this type are underway in France, particularly with vulnerable clinical populations (adolescents/adults). The inclusion of a process-centered approach (Kinderman, 2015), in a transdiagnostic and preventive way, constitutes an innovative approach.
Eligibility Criteria
Inclusion Criteria: * Age 12-65 years * Adolescent population considered as at risk in mental health : admitted to the peadiatric department (CHMS). or - Adult population : user of the Espoir73 association (an association for adults with a mental health problem) or users of SM@RT (CHS, a psycho-social rehabilitation center for adults with a mental illness). Exclusion Criteria: \- No suicidal ideation or behaviors (none " Yes " response at the 6 questions of the C-SSRS screen version).
Frequently Asked Questions
Who can join the NCT06921226 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 65 Years, studying Suicidal Ideas. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06921226 currently recruiting?
Yes, NCT06921226 is actively recruiting participants. Visit ClinicalTrials.gov or contact Centre Hospitalier Metropole Savoie to inquire about joining.
Where is the NCT06921226 trial being conducted?
This trial is being conducted at Chambéry, France, Bassens, France, Francin, France.
Who is sponsoring the NCT06921226 clinical trial?
NCT06921226 is sponsored by Centre Hospitalier Metropole Savoie. The trial plans to enroll 1,400 participants.